Roflumilast is a phosphodiesterase-4 (PDE4) inhibitor used to treat chronic obstructive pulmonary disease (COPD) and severe asthma. It works by reducing inflammation in the lungs and preventing bronchospasm. Roflumilast helps improve lung function and reduce the frequency of COPD exacerbations.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Roflumilast and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Roflumilast impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Roflumilast-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
